Home » BioLineRx Inks In-License Agreement with Israeli Institutions for Type 1 Diabetes Treatment
BioLineRx Inks In-License Agreement with Israeli Institutions for Type 1 Diabetes Treatment
BioLineRx has signed agreements with a number of Israeli institutions to develop and market its Type 1 diabetes antibody treatment.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May